Announcing our newest cancer test. Screen cancer early with Onco-D-clare. Learn more

Our tests | Onconomics panels

Onconomics Plus

Onconomics Plus is our most comprehensive treatment testing tool that provides information to help build cancer treatment protocols for patients. 

The Onconomics Plus panel provides information about the following details.

  • Circulating tumor cell (CTC) count 
  • Genetic and physiological expressions of your cancer cells 
  • Effectiveness of 90+ chemotherapeutic agents and targeted therapies on your cancer cells
  • Effectiveness of 50+ natural substances on your cancer cells

The Onconomics Plus test is performed on a sample of your blood using our liquid biopsy technique. 

Onconomics Plus

How the test works

The Onconomics Plus test returns information crucial for devising individualized treatment plans for each patient. 

Even with the same cancer type diagnosis, no two patients are the same.

Your individual biology and how the cancer cells behave in your body are unique to you. Personalizing treatment for individual patients can, therefore, offer a better chance for treatment to be effective.

Let’s look at the type of information returned as part of the Onconomics Plus panel.

CTC count

The Onconomics Plus panel returns your CTC count, which measures the volume of the cancer cells in your bloodstream. Knowing the pattern of movement of your CTC count - whether it is increasing or decreasing - can guide treatment choices toward achieving better results.

Genetic and physiological expressions

Genetic expressions define how the information in a gene is turned into a function. For example, the genetic expressions of your cancer cells can reveal how quickly your cancer cells adapt to become resistant to treatment. 

Knowing this information can guide how your treatment protocols are set up. For instance, the treatment plan can ensure that your treatment protocols are rotated on a shorter timeline so that they can benefit you before the cells become resistant. 

The profile with genetic expressions is helpful in customizing treatment protocols for each individual patient. This is because each patient’s gene expressions are unique to them, like a fingerprint or blueprint specific to them. 

This data gives your practitioner information that helps them add treatment options based on these expressions, enhancing your cancer care.

Chemotherapeutic agents

The Onconomics Plus test also tests over 50 chemotherapeutic substances (and 60+ targeted drugs) on your cancer cells to see which ones are effective in targeting these cells. 

Chemotherapeutic agents are known to be harsh on the body. Whether it effectively targets cancer or not, chemotherapy takes a toll on the human body. 

With conventional treatment models, a one-size-fits-all approach is used. This means that as a patient, you have limited information on what other treatment options are available (and may work) for your specific case. In this case, you cannot make an educated choice on the type of treatment that may be best for you. 

With our Onconomics Plus panel, personalized information can finally be accessed by both patients and their healthcare providers. Knowing the specific chemotherapeutic agents that are better for your cancer places the power of choice back in your hands. And you are no longer going into your treatment journey blindly on a wing and a prayer.

Natural substances

Many natural substances are known to have cancer-targeting properties. However, not all substances work equally for every patient. While some patients may benefit from turmeric or high doses of vitamin C, others may see no change in their cancer status.

The Onconomics Plus panel takes the guesswork out of the picture and tests over 50 natural substances on your cancer cells. This information provides evidence on which substances will likely have the greatest chance of showing positive results for your body and cancer.

Additional substances

We can also include five additional substances in the price of the Onconomics Plus test. Each additional substance beyond the five is charged separately, but there is no upper limit to how many you can add. 

If a patient wants to test a substance that is not on our list, we can accept small samples of the said substance(s) in the lab along with the blood sample. Here is a guideline on how to package a physical sample to ship to our lab when needed.

Using the Onconomics Plus panel for best results

The Onconomics Plus panel is an incredibly empowering tool that patients and practitioners can use to find out exactly what types of treatments can help each individual patient. 

When a patient partners with us, we begin by establishing a baseline of their readings with the OncoTrace test. The patient’s care team has this information as a yardstick against which progress can be measured going forward.

Patients follow this up with our Onconomics Plus panel to receive comprehensive information on the efficacy of various types of treatment protocols for their cancer.

This test provides data about each patient and the genetic behavior of the specific cancer in their body. It is our most comprehensive and detailed testing panel offering individualized patient profiles.

Although the test results are quite technical in nature, your accredited practitioner can help you interpret these results and guide you on your treatment journey. While some treatment options may not be part of conventional treatment models, your care team can guide you through the process of identifying suitable treatments based on our test panel recommendations.

What to expect during testing

For the Onconomics Plus panel, a liquid biopsy is performed with a sample of blood drawn from your body. Patients provide us with their blood samples; no surgery or tissue biopsy is needed.

All samples are shipped to our international laboratory in Greece. All our accredited practitioners and clinicians understand our shipping instructions and ensure the samples arrive in perfect condition. Test results can take 7-10 days from arrival at the lab to be ready.

Price in Euros: EUR 2050

* Prices in $USD vary slightly based on the exchange rate on the day the test is ordered.
** These prices do not include in-office fees such as consultation, blood draws, IV administration, etc.

View a sample Onconomics Plus report

To know what to expect from the test results, view a sample Onconomics Plus report here.

Accessing the results

Your sample will be processed at our state-of-the-art laboratory in Greece. Once the test is completed, we will provide a detailed breakdown of our findings. The results are sent to your accredited practitioner, who downloads the report and sets up an appointment with you to go over the results.

We recommend that you also discuss the results with your cancer care team and work together to develop a personalized treatment plan based on our findings.

Access cutting-edge cancer care tools with our Onconomics Panels

Our scientists use world-leading technology, equipment, and innovative techniques to develop a range of cancer screening and monitoring tests. Our tests help cancer patients and their healthcare professionals get a comprehensive but personalized view of each patient’s genetics, physiology, and immune profiles.

We believe this level of detail is crucial in developing an individualized care plan for every patient struggling with cancer. We aim to provide a unique insight into every patient’s cancer biology to empower them about what treatment modalities are ideal for bringing them success in their cancer journey!

Reach out to us to start your journey to empowering information for your cancer treatment today by contacting us online.

IAS Accreditation
Testing Laboratory
View TL-836 Certificate
EN ISO 22000: 2018
No: 20101200002689
View Certificate
IAS Accreditation
Medical Laboratory
View ML-103 Certificate
ISO 22000: 2018
No: 20101200002689
View Certificate
ISO 45001: 2018
No: 20152220006395
View CertificatePolicy
ISO 22716: 2007
No: 20019220006394
View Certificate
CLIA ID Number
View Certificate
College of American Pathologists 
Certificate of Accreditation
CAP#: 9239089 
CLIA#: 99D2283882 
View Certificate
Certificate of GMP Compliance
No. 512863-102689104
View Certificate